Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-19

FDA Approved: BUMETANIDE — Original Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved bumetanide (Original Application) by Qilu Pharmaceutical as a generic diuretic for edema associated with congestive heart failure, hepatic disease,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)